← Back to Search

BRITEPath for Suicidal Thoughts

N/A
Waitlist Available
Led By Stephanie Stepp, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Youth aged 12-26yo
Own a device (e.g. smartphone, iPod, tablet) with capability to download BRITE app
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at exit interview following week 4 study visit or week 12 study visit (depending on when youth attends mental health session that uses britepath tools)
Awards & highlights

Study Summary

BRITEPath- Phase 2

Eligible Conditions
  • Suicidal Thoughts
  • Depression

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at exit interview following week 4 study visit or week 12 study visit (depending on when youth attends mental health session that uses britepath tools)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at exit interview following week 4 study visit or week 12 study visit (depending on when youth attends mental health session that uses britepath tools) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mental Depression
Quality of Life and Social/Emotional Functioning
Service Utilization (Outpatient, School, ER, Legal, Inpatient, Medication)
+1 more
Secondary outcome measures
Application Utilization-BRITE App Use by Participants
Application Utilization-Number of Participants With Provider Who Completed Guide2BRITE Onboarding Process
Cost Estimate for Implementation of BRITEPath Intervention
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BRITEPathExperimental Treatment1 Intervention
Participants will receive the components in BRITEPath from a mental health (MH) clinical trained by the study staff/PI's on how to implement BRITE safety planning with fidelity. First, the MH clinician will review possible barriers to implementation of the safety plan and problem-solve appropriately with patient and parent(s); (2) BRITE is the emotion regulation/safety planning app loaded on the patient's smartphone that populated with support from Guide2BRITE; and (3) BRITEBoard, a clinician dashboard that shows app use, change in distress and symptoms ratings, and can be used for shared decision making with parents, patients, and PCPs. Clinicians will review adolescent's skill development and app content with parents. Prior to discharge or following acute increases in suicide risk.
Group II: Treatment As Usual (TAU)Active Control1 Intervention
Participants in the TAU group will receive treatment from their mental health clinician which may include safety planning.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BRITEPath
2020
N/A
~150

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,716 Previous Clinical Trials
16,346,353 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,777 Previous Clinical Trials
2,674,271 Total Patients Enrolled
1 Trials studying Suicidal Thoughts
240 Patients Enrolled for Suicidal Thoughts
Kaiser Foundation Research InstituteOTHER
27 Previous Clinical Trials
21,195 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~23 spots leftby Mar 2025